Stay updated on CD19/22 CAR T Cells in DLBCL Clinical Trial
Sign up to get notified when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.

Latest updates to the CD19/22 CAR T Cells in DLBCL Clinical Trial page
- Check4 days agoChange DetectedUpdated record dates for NCT03287817, including Last Update Posted 2025-07-14 and Results First Posted 2025-07-14; no changes to study design, eligibility criteria, or AUTO3 treatment details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedUpdated operating status notice and new resource entry; version bumped from v3.1.0 to v3.2.0.SummaryDifference2%

- Check33 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0 with an added update marker; no substantive content or critical data changes detected.SummaryDifference0.3%

- Check47 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, indicating a minor revision; the 'Back to Top' link was removed. Overall, changes are limited to the version bump and a small navigation change.SummaryDifference0.1%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

- Check62 days agoChange DetectedThe web page has updated its facility name and location details, specifically emphasizing St. Louis, Missouri, and has introduced new medical terminology related to diffuse large B-cell lymphoma. Additionally, the revision number has been updated to v3.0.0.SummaryDifference2%

Stay in the know with updates to CD19/22 CAR T Cells in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.